(Q27853039)

English

Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

scientific article

In more languages

Statements

scholarly article

2 references

13 November 2016

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group (English)

2 references

13 November 2016

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

childhood acute myeloid leukemia

1 reference

based on heuristic

inferred from title

Hidemasa Matsuo

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Daisuke Tomizawa

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

M Kajihara

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

T Watanabe

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

A M Saito

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

J Fujimoto

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

K Horibe

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

K Kodama

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

M Tokumasu

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

H Itoh

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

H Nakayama

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

A Kinoshita

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

T Taga

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

A Tawa

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

T Taki

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

S Tanaka

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

S Adachi

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

11 July 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Blood Cancer Journal

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

e226

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

7

0 references

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

1 July 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

20 March 2017

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

20 March 2017

E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

20 March 2017

Novel mutations in CEBPA in Korean Patients with acute myeloid leukemia with a normal karyotype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

29 September 2017

Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

29 September 2017

Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

29 September 2017

Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

29 September 2017

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

29 September 2017

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

29 September 2017

CEBPA point mutations in hematological malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

29 September 2017

C/EBPalpha mutations in acute myeloid leukaemias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

29 September 2017

Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

29 September 2017

c-Myc is a critical target for c/EBPalpha in granulopoiesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

29 September 2017

Transcription factors, normal myeloid development, and leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219441

2 June 2018

Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2014.47

21 January 2018

The role of different genetic subtypes of CEBPA mutated AML.

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2014.47

21 January 2018

Prognostic significance of the BAALC isoform pattern and CEBPA mutations in pediatric acute myeloid leukemia with normal karyotype: a study by the Japanese Childhood AML Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2014.47

21 January 2018

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2014.47

21 January 2018

CEBPA single mutation can be a possible favorable prognostic indicator in NPM1 and FLT3-ITD wild-type acute myeloid leukemia patients with intermediate cytogenetic risk

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2014.47

21 January 2018

Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2014.47

21 January 2018

Recurrent in-frame insertion in C/EBPα TAD2 region is a polymorphism without prognostic value in AML

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2014.47

21 January 2018

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25014773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preview. Mutant CEBPA: Priming Stem Cells for Myeloid Leukemogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25014773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25014773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/25014773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A recurrent in-frame insertion in a CEBPA transactivation domain is a polymorphism rather than a mutation that does not affect gene expression profiling-based clustering of AML

1 reference

https://pubmed.ncbi.nlm.nih.gov/25014773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CEBPalpha mutations in childhood acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25014773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BCJ.2014.47

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Dimensions Publication ID

0 references

2 references

13 November 2016

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2 references

13 November 2016

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25014773%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

ResearchGate publication ID

0 references

Springer Nature article ID

10.1038/bcj.2014.47

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27853039&oldid=1861216019"